OrbiMed's continued large-scale selling—now $46.3M in a single notice plus $48.9M in recent sales—signals potential overhang and lack of insider conviction. Despite strong analyst sentiment, the persistent insider distribution warrants caution. Monitor for actual execution and any further 144 filings.
Price Chart
Executive Summary
OrbiMed Advisors LLC filed a Form 144 on May 29, 2026, signaling intent to sell 1,082,480 shares of Sionna Therapeutics common stock, valued at approximately $46.3 million. This represents a large-scale sell by a major pre-IPO investor, following a series of recent sales by the same entity totaling over $39 million in April–May 2026.
Key Facts
- OrbiMed Advisors LLC (via OrbiMed Private Investments VIII, LP) filed Form 144 to sell 1,082,480 shares of SION common stock.
- Estimated aggregate value of proposed sale: approximately $46.3 million.
- Shares were acquired on 02/10/2025 in the IPO for cash.
- OrbiMed has sold 1,082,480 shares in the past 3 months (since 04/14/2026) totaling ~$48.9 million.
- Recent insider selling (30d) totals $26.7M across 6 transactions, all by OrbiMed.
- Market cap is $1.9B; proposed sale represents ~2.4% of market cap.
- Sionna has 88% analyst bullish consensus (6 Strong Buy, 8 Buy).
Financial Impact
Proposed sale of 1,082,480 shares valued at ~$46.3M, representing ~2.4% of SION's $1.9B market cap.
Risk Factors
- Continued insider selling pressure from a major pre-IPO holder.
- Potential negative signal about near-term prospects or valuation.
- Possible further dilution if OrbiMed continues to reduce its position.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000947871-26-000586 |
| Document: 0000947871-26-000586-index.html | 0000947871-26-000586 |
| Document: 0000947871-26-000586.txt | 0000947871-26-000586 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 10, 2026 7w ago | 8-K | $4.50 $7.30 | ▼ −62.22% | ▼ −63.14% | $5.04 (−12.00%) |
Aug 6, 2026 8w ago | 8-K | $49.61 $6.75 | ▼ −86.39% | ▼ −86.99% | $5.04 (−89.84%) |
Jul 9, 2026 12w ago | Insider Cluster | $45.29 $51.04 | ▲ +12.70% | ▲ +10.27% | $5.04 (−88.87%) |
Jul 9, 2026 12w ago | Insider Cluster | $45.29 $51.04 | ▼ −12.70% | ▼ −10.27% | $5.04 (+88.87%) |
Jul 7, 2026 12w ago | Insider Cluster | $44.00 $47.34 | ▼ −7.59% | ▼ −4.32% | $5.04 (+88.55%) |
Jul 2, 2026 13w ago | Insider Cluster | $43.99 $46.78 | ▲ +6.34% | ▲ +6.76% | $5.04 (−88.54%) |
Jun 11, 2026 16w ago | Institutional Cluster | $36.05 $44.94 | ▲ +24.66% | ▲ +22.77% | $5.04 (−86.02%) |
May 30, 2026 17w ago | Insider Cluster | $40.90 $43.99 | ▲ +7.55% | ▲ +8.85% | $5.04 (−87.68%) |
May 29, 2026 17w ago | 144 | $40.90 $43.99 | ▼ −7.55% | ▼ −8.85% | $5.04 (+87.68%) |
May 12, 2026 20w ago | 8-K | $40.94 $34.03 | ▼ −16.88% | ▼ −15.15% | $5.04 (−87.69%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access